Findings in 6 Patients with Rare Lung Tumors and Metastatic Lung Disease
| FACS analysis | ||||||
|---|---|---|---|---|---|---|
| Patient no. | Age (y) | Sex | Histopathology | 68Ga-pentixafor PET SUVmax | MFI | CXCR-positive tumor cells (%) |
| 1 | 73 | F | Sarcomatoid carcinoma (primary tumor) | 6.34 | 110.50 | 2.70 |
| 2 | 33 | F | Hemangioendothelioma (primary tumor) | 13.0 | 682.0 | 73.60 |
| 3 | 68 | M | Hemangiopericytoma (primary tumor) | 3.0 | 27.90 | 2.50 |
| 4 | 70 | F | Lung metastasis (primary sarcoma) | 9.5 | 191.20 | 45.2 |
| 5 | 40 | M | Lung metastasis (primary renal cell carcinoma) | 6.0 | 62.0 | 47.0 |
| 6 | 58 | M | Lung metastasis (unknown primary) | 7.5 | 216.6 | 59.2 |